Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarEmerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Altos LabsHealthcare
Biotech & Pharma
Low$xx.xx$xx.xx$xx.xxxx%--------$18.00+28.57%+5.88%$11.13BSeries C2/14/2024$1.5B$6.33B$25.02Undisclosed Investors
ResilienceHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$4.18BSeries D6/6/2022$625M$8.84B$60.73Undisclosed Investors
Kailera TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$959.96MSeries B10/14/2025$603.18M$1.4B$14.00Bain Capital, Adage Capital Management, Canada Pension Plan Investment Board, Invus, Janus Henderson Investors, Perseverance Capital, QIA, Royalty Pharma, Surveyor Capital, T. Rowe Price, Atlas Venture, Bain Capital Life Sciences, RTW Investments, Sirona Capital
EQRxHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$813.88MSeries B1/11/2021$570M$1.66B$2.74GV, Bain Capital Life Sciences, Andreessen Horowitz, ARCH Venture Partners, Arboretum Ventures, Casdin Capital, Nextech, Section 32
Xaira TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1BSeries A4/23/2024$500M$2.65B$2.50ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, Rsquared, SV Angel, AIM13, Breyer Capital, Deviation Capital, Foresite Labs, JSL Health Capital, Longwood Fund, Sahsen Ventures, WRF Capital
LyellHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.04BSeries C3/5/2020$493M$2.5B$11.49ARCH Venture Partners, Foresite Capital, Milky Way Investments
Intarcia TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$961.46MSeries EE9/15/2016$475.68M$3.94B$60.00Baillie Gifford, Luxin Venture Capital, Fidelity Investments, RA Capital Management, Foresite Capital Management, The Pritzker Organization, The Baupost Group
Chai DiscoveryHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$620.17MSeries C7/14/2026$400M$3.8B$178.05Index Ventures, Kleiner Perkins, Sequoia Capital, Dimension, Bain Capital Ventures, Battery Ventures, Baillie Gifford, BDT & MSD, Sapphire Ventures, Avra Capital, Thrive Capital, OpenAI, Oak HC/FT, Menlo Ventures, General Catalyst, Glade Brook, Avenir, Lachy Groom, Yosemite, Scribble Ventures
InsitroHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.26BSeries C3/15/2021$400M$2.57B$18.29CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank
Generate BiomedicinesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$812.92MSeries C1/21/2025$399.4M$2.22B$11.85Amgen, Nvidia, MAPS Capital, Pictet Alternative Advisors, Flagship Pioneering, Abu Dhabi Investment Authority, Fidelity, T. Rowe Price, ARCH Venture Partners, March Capital, Alaska Permanent Fund, Altitude Life Science Ventures, Novartis
GrailHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$2.02BSeries D5/6/2020$392.01M$4.26B$5.11Public Sector Pension Investment Board, Canada Pension Plan Investment Board, Illumina
Colossal BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%$306.00K--1--Not available----$620.64MSeries C2/3/2026$380M$10.32B$24.89TWG Global, Peter Jackson, US Innovative Technology Fund, Robert Nelsen, United Arab Emirates
Formation BioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$3.38BSeries D6/26/2024$372M$1.48B$8.18Andreessen Horowitz, Sanofi, Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, SV Angel Growth, FPV Ventures
Ginkgo BioworksHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$785.53MSeries E5/28/2020$360M$4.89B$150.19T. Rowe Price, Allen & Company, Baillie Gifford, Cascade Investment, General Atlantic, Reshape Holdings, Viking Global Investors, Illumina
Eikon TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.16BSeries D2/14/2025$350.7M$1.85B$5.84Lux Capital, Alexandria Venture Investments, AME Cloud Ventures, The Column Group, E15 VC, Foresite Capital, General Catalyst, Soros Capital, StepStone Group, T. Rowe Price, UC Investments
ArsenalBioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$2.44BSeries C9/4/2024$327.5M$1.66B$18.58ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures
Kriya TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$940.5MSeries D9/10/2025$320.82M$1.67B$10.34Patient Square Capital, Premji Invest, Peter Thiel, Narya Capital, The T1D Fund
ValoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$406.25MSeries B3/9/2021$310M$919.92M$5.88PSP Investments, Flagship Pioneering, Invus Public Equities, HBM Healthcare Investments, Atinum Investment, Mirae Asset Capital, Koch Disruptive Technologies
Parabilis MedicinesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$811.88MSeries F1/8/2026$305.25M$681.2M$6.16RA Capital Management, Fidelity, Janus Henderson Investors, Frazier Life Sciences, Soleus Capital, venBio Partners, Cormorant Asset Management, Nextech Invest, ARCH Venture Partners, Milky Way Investments, GV, T. Rowe Price, Marshall Wace, General Catalyst, Invus, Farallon Capital Management, Foresite Capital, Rock Springs Capital, HBM Healthcare Investments, Samsara BioCapital, Catalio Capital Management, Sixty Degree Capital, Alderline Group
MedableHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$530.96MSeries D10/26/2021$304.88M$2.1B$9.67Blackstone Growth, Tiger Global, GSR Ventures, Sapphire Ventures, WTI
AcelyrinHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$558MSeries C9/9/2022$300M$809.52M$6.22Access Biotechnology, Matrix Capital Management, Westlake Village BioPartners, Cowen Healthcare Investments, Decheng Capital, Marshall Wace, OrbiMed, Samsara BioCapital, Surveyor Capital, Tybourne Capital Management, venBio Partners
Solve TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$296.39MSeries A11/17/2025$296.39M$426.7M$4.41Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, Alexandria Venture Investments, AyurMaya Capital Management, DC Global Ventures, Matrix Capital Management, Decheng Capital, General Atlantic, Surveyor Capital
Sonoma BiotherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$365.1MSeries B-13/28/2023$147.78M$732.39M$2.96Ally Bridge Group, ArrowMark, Avidity Partners, Casdin Capital, Deep Track Capital, Fidelity Management, Frazier Healthcare Partners, GV, Janus Henderson Investors, Mirae Asset, NS Investment, Osage University Partners, Piper Heartland Healthcare Capital, Vertex Ventures HC, 8VC, ARCH Venture Partners, Alexandria Venture Investments, JDRF T1D Fund, LifeForce Capital, Lilly Asia Ventures Biosciences, Octagon Capital, Regeneron
ReCode TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$397.77MSeries B9/23/2025$290M$588.16M$9.23Matrix Capital Management, Pfizer Ventures, EcoR1 Capital, Sanofi Ventures, Tekla Capital Management, Superstring Capital, NS Investment, OrbiMed, Vida Ventures, MPM Capital, Colt Ventures, Hunt Technology Ventures, Osage University Partners, Bayer, Amgen, CF Foundation

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.